Lok Sabha Question No. 247 (UNSTARRED), answered on 2020-02-04
Subject: Implementation of PMBJP
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Shriniwas Dadasaheb Patil, Ramya  Haridas, Sunil Dattatray Tatkare, Amol Ramsing Kolhe, Kuldeep Rai Sharma, DNV Senthilkumar. S., Supriya Sadanand Sule, Subhash Ramrao Bhamre

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No.  247 TO BE ANSWERED ON 4 th  February, 2020

## Implementation of PMBJP

## 247. SHRI SHRINIWAS PATIL:

MS. RAMYA HARIDAS: SHRI SUNIL DATTATRAY TATKARE: DR. AMOL RAMSING KOLHE: SHRI KULDEEP RAI SHARMA: DR. DNV SENTHILKUMAR S.: SHRIMATI SUPRIYA SULE: DR. SUBHASH RAMRAO BHAMRE:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) the salient features of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) being implemented by the Government;
- (b) the nodal agency for implementing PMBJP along with the funding mechanism for PMBJP;
- (c)  the  number  of  medicines  and  surgical  and  consumable  items  covered  under PMBJP;
- (d) whether the Government has appointed any steering Committee to monitor the progress of implementation of the project and the target achieved, if so, the details and the outcome thereof;
- (e)  the  other  steps  taken  by  the  Government  to  provide  the  complete  spectrum of healthcare  products  and  services,  starting  from  making  available  all  the  generic drugs covering all the therapeutic groups under PMBJP;
- (f)  whether  it  is  a  fact  that  PMBJP  has  failed  to  attract  pharmaceutical  companies and has managed to achieve only a limited success; and
- (g) if so, the details thereof and the reasons therefor along with the steps being taken to overcome the problems faced in the implementation of PMBJP in the country?

## ANSWER

## MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI D. V. SADANANDA GOWDA)

- (a) Under the Pradhan Mantri Bhartiya  Janaushadhi  Pariyojana,  special  outlets namely  Janaushadhi  Kendras  are  being  opened  across  the  country  for  making available quality generic medicines at affordable prices for the masses. The Scheme is operated by government agencies as well as by private entrepreneurs. Under this scheme, Government is providing financial assistance to the operating agencies in the following manner:
-  An amount of Rs.2.50 lakh is extended to any person establishing Janaushadhi  Kendra  in  government  hospital  premises  where  space  is provided free of cost by Government to operating agency:-
- -Rs. 1 lakh reimbursement of furniture and fixtures
- -Rs. 1 lakh by way of free medicines in the beginning
- -Rs. 0.50 lakh as reimbursement  for computer, internet, printer, scanner, etc.
-  Janaushadhi  Kendra  opened  by  any  individual  entrepreneurs  at  private premises is extended an incentive of 15% of monthly purchases subject to a ceiling of Rs. 10,000/ per month upto a total limit of Rs. 2.5 lakh. Individual SC/ST and differently-abled  entrepreneurs  are  provided  medicines  worth  of Rs. 50,000/- in advance.
-  For  north  eastern  states,  naxal  affected  areas  and  tribal  areas,  the  rate  of incentive will be 15% subject to a monthly ceiling of Rs. 15,000/- upto a total limit of Rs. 2.5 lakhs.
-  Prices of the Jan Aushadhi medicines are 50%-90% less than that of branded medicine's prices available in the open market.
-  Medicines procured only from World Health Organization -Good Manufacturing  Practices  (WHO-GMP)  certified  suppliers  for  ensuring  the quality of the products.
-  Each  batch of drug is tested at laboratories accredited by 'National Accreditation  Board  for  Testing  and  Calibration  Laboratories' (NABL)  for ensuring best quality.

(b)  PMBJP is being implemented through Bureau of Pharma PSUs of India (BPPI) which is a registered society, working under the administrative control of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. BPPI receives grant from Department of Pharmaceuticals, Government of India, as well as generates revenue from sales of medicines.

(c)  The  product  basket  of  PMBJP  comprises  854  medicines  and  154  surgicals  & consumables  covering  all  major  therapeutic  groups  such  as  Anti-infective,  Antiallergic, Anti-diabetic, Cardiovascular, Anti-cancer, Gastro-intestinal medicines, etc.

(d) Department of Pharmaceuticals, monitors and reviews the scheme regularly.

(e) Presently, 854 medicines and 154 surgicals and consumables are available in the medicine basket of PMBJP. The endeavor is to analyze the various market trends and  accordingly  make  available  enhanced  range  of  products.  It  is  a  continuous process based on feedback of various stakeholders and market demands. The plan is to expand this basket to 1200 medicines and 200 surgicals by March, 2020.

(f)  &  (g)  No  Sir.  The BPPI has more than 150 WHO-GMP certified pharmaceutical companies  as  its  regular  vendors.  These  include  reputed  companies  like  Cipla, Abbott,  Wockhardt,  Zee  Laboratories,  Micro  Lab,  Biocon,  etc.  for  procurement  of drugs and surgicals. BPPI regularly conduct meetings with reputed companies and invites them to participate in its tenders.

*****